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Abstract.  A  heparan sulfate proteoglycan (HSPG) 
synthesized by murine parietal yolk sac (PYS-2)  cells 
has been characterized and purified from culture su- 
pernatants. A  monospecific polyclonal antiserum was 
raised against it which showed activity against the 
HSPG core protein and basement membrane specific- 
ity in immunohistochemical studies on frozen tissue 
sections from many rat organs. However, there was no 
reactivity with some basement membranes, notably 
those of several smooth muscle types and cardiac mus- 
cle. In addition, it was found that pancreatic acinar 
basement membranes also lacked the HSPG type rec- 
ognized by this antiserum. Those basement mem- 
branes that lacked the HSPG strongly stained with 
antisera against laminin and type IV collagen. The 
striking distribution pattern is possibly indicative of 
multiple species of basement membrane HSPGs of 
which one type is recognized by this antiserum. Fur- 
ther evidence for multiple HSPGs was derived from 
the finding that skeletal neuromuscular junction and 
liver epithelia also did not contain this type of HSPG, 
though previous reports have indicated the presence of 
HSPGs at these sites. 
The PYS-2 HSPG was shown to be antigenically 
related to the large, low buoyant density HSPG from 
the murine Engelbreth-Holm swarm tumor. It was, 
however, confirmed that only a  single population of 
antibodies was present in the serum.  Despite the pres- 
ence of similar epitopes on these two proteoglycans of 
different hydrodynamic properties,  it was apparent that 
the PYS-2  HSPG represents a basement membrane 
proteoglycan of distinct properties reflected in its re- 
stricted distribution in vivo. 
B 
ASEMENT membranes and a  variety of cell surfaces 
have been shown to contain heparan sulfate proteogly- 
cans (HSPGs) l  (see reviews  13,  15,  17,  26).  Those 
from cell surfaces appear to have hydrophobic characteristics 
which indicate that their core proteins may be distinct from 
the basement membrane HSPGs, these being extracellular 
matrix components. The cell-associated HSPGs have been 
strongly implicated with a  role in cell adhesion processes 
(17, 21, 40), while the basement membrane forms, notably 
those found in the kidney glomerulus, are thought to control 
macromolecular permeability of their respective basement 
membranes (19). More recently, concentrations of HSPG in 
the neuromuscular junction basement membrane have been 
described which may have a role in the orientation or local- 
ization of acetylcholinesterase (1,  2).  However,  for most 
basement membranes,  the role of HSPG is presently not 
understood. 
There is a  strong probability that basement membranes 
contain a family of proteoglycans, including some forms of 
chondroitin sulfate proteoglycan (CSPG)  (5,  13,  18) and a 
potential candidate for one such proteoglycan from PYS-2 
1. Abbreviations  used in this paper: CS, chondroitin sulfate; DS, dermatan 
sulfate; EHS, Engelbreth-Holm swarm; HS, heparan sulfate; PG, proteo- 
glycan. 
cell cultures has been identified (8). I aimed to characterize 
a basement membrane HSPG secreted by PYS-2  cells, and 
then, by immunochemical analysis, determine its relation- 
ship to other HSPGs and ubiquity in basement membranes. 
As an increasing number of extracellular matrix proteogly- 
cans, including HSPGs, have now been described from cell 
cultures  and  in  vivo  sources  (13, 15,  26,  and references 
therein), it was felt to be necessary in this study to correlate 
structure with immunochemical and distribution data so that 
when protein core sequence data becomes available proteo- 
glycan relationships can be more easily established. The sit- 
uation is not straightforward in that both large, low density 
and small, high density HSPGs have been reported from 
PYS-2  cells (33)  and the murine Engelbreth-Holm swarm 
(EHS) tumor, a rich source of basement membrane macro- 
molecules (10, 14). The two HSPGs from the EHS tumor are 
immunochemically related (10, 14), which has given rise to 
the thesis that the smaller HSPG is a proteolytic product of 
the larger form, and that such processing may, to some ex- 
tent, explain the wide variation in HSPG sizes from tissue 
sources (14, 15, 33).  In addition, antibodies raised against 
EHS tumor HSPGs cross react with HSPGs from PYS-2 
cells and a rat yolk sac tumor (10, 33, 38). 
Previous studies with PYS-2 cells have shown the synthe- 
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(DSPG) (8, 10, 24, 33). In this report, a small, high density 
HSPG has been purified from bulk culture supernatants and 
a  monospecific antiserum raised against  it.  Immunohisto- 
chemical analysis showed that not all basement membranes 
contain this HSPG, nor is there a concentration of it in the 
neuromuscular junction. The HSPG is also immunochemi- 
cally unrelated to that found on cell surfaces and does not 
stain  liver epithelial cells,  consistent with  the notion that 
HSPGs with hydrophobic properties have different core pro- 
tein and functional capabilities. However, it remains highly 
likely that there are other HSPGs specific to basement mem- 
branes  which  may  have  distinct  core proteins  and  fulfill 
different roles in basement membrane physiology. This is 
particularly borne out by the finding that not all basement 
membranes contain the type of HSPG reported here. 
Materials and Methods 
Materials 
Cell culture reagents were from Flow Laboratories, Inc., McLean, VA. Tis- 
sue culture flasks and dishes were from Corning Glass Works, Corning, NY. 
Roller culture flasks were from Sterilin Ltd., Teddington, Middlesex, UK. 
Na2 "SO4 was from Amersham Corp., Arlington Heights, IL (specific ac- 
tivities  1,440  Ci/mmol).  DEAE-Sephacel,  Sepharose CL-4B,  Sephadex 
G-50 and G-200, and Mono Q column were all obtained from Pharmacia 
Fine Chemicals, Uppsala, Sweden. All other chemicals were from Sigma 
Chemical Co., St.  Louis, MO or Fisher Chemicals, Fairhaven, NJ. Chon- 
droitinase ABC, heparitinase, and heparinase were from Miles Laborato- 
ries, Inc., Elkhart, IN, and leech hyaluronidase was from Biopharm (U.K.) 
Ltd.,  Swansea, Glamorgan, UK. 
Cells: Culture and Experimental Conditions 
PYS-2 ceils, a teratocarcinoma-derived cell line related to the parietal en- 
dodermal cells of the mouse embryo (22) were grown at 37~  in DME con- 
raining 8%  FBS,  25  I.tg/ml ascorbic acid,  1 mM serine, 2  mM proline, 
1 mM sodium pyruvate, and 30 nM each of adenosine, cytidine, guanosine, 
and uridine. Some cultures in 100-mm petri dishes were radiolabeled with 
20  laCi/ml  [35Slsulfate  for 3  d.  For bulk cultures, cells were grown for 
3-6 d  in  150-cm  2 flasks or  roller  bottles.  Medium from large or  small 
batches was decanted and centrifuged at  1,000  rpm in a  TJ-6 centrifuge 
(Beckman Instruments, Inc., Palo Alto, CA) with TH-4 rotor and the super- 
natants were then further processed for the purification of proteoglycans. 
A  similar murine cell line, PF-HR9, was grown in DME containing 10% 
FBS. 
Purification and Analysis of  HSPGs  from PYS-2 
Culture Supernatants 
All buffers contained the protease inhibitors EDTA, phenylmethylsulfonyl 
fluoride (PMSF), and N-ethylmaleimide in addition to sodium azide at con- 
centrations of 20, 0.2, and  10 mM, and 0.02%  respectively. Radiolabeled 
medium from PYS-2 cultures was made 0.2 mM with PMSE  10 mM with 
N-ethylmaleimide, and 4 M with urea before isolation of the proteoglycans 
on a column of DEAE-Sephacel as previously described (8). Labeled pro- 
teoglycans were then eluted with a gradient from 0.2-1.5 M NaCl in 0.05 M 
sodium acetate, pH 4.0, containing 4 M urea. Fifty 4-ml fractions were col- 
lected;  i00 I.tl of each was analyzed for radiolabel, and the conductivity of 
every third fraction was also measured. 
CS/DS was removed by overnight treatment at 37~  with 0.2 U/ml chon- 
droitinase ABC in 0.05 M Tris acetate, pH 8.0, containing 10 mM EDTA, 
5 mM N-etbylmaleimide, 0.2 mM PMSE  and 20 mM pepstatin followed 
by a repurification on a 3 x  1-cm column of DEAE-Sephacel as before. The 
digestion products of chondroitinase ABC action did not rebind DEAE- 
Sephacel under the conditions used. For analysis of CS/DS and HS content, 
gel chromatography was performed on a 30  ￿  2-cm column of Sephadex 
G-50 after chondroitinase ABC or nitrous acid (30) treatments. The column 
was equilibrated in 1 M NaCI and run at 15 ml/h. 2-ml fractions were col- 
lected and analyzed for radiolabel. 
Size analysis of the proteoglycan was carried  out on a  90  x  1.5-cm 
column of Sepharose CL-4B equilibrated with 0.1%  SDS, 0.35 M  NaCI, 
0.05  M  Tris-HCl, pH 8.0, or Dulbecco's PBS, both run at 6 ml/h.  1.5-ml 
fractions were collected for radiolabeled analysis. To examine whether the 
proteoglycans existed in disulfide-bonded aggregates, samples were boiled 
for 3 min in the SDS-containing buffer with 2  mM dithioerythreitol.  Re- 
duced samples were cooled, alkylated with excess 0.5 M  iodoacetamide, 
and chromatographed on the column of Sepharose CL-4B. 
Glycosaminoglycan chain size was determined after alkaline elimination 
(8)  and chromatography on a  column of Sepharose CL-4B as above or 
Sephadex G-200 equilibrated with 0.2 M  NaCI (36). Columns were run at 
6 ml/h and 1.5-ml fractions collected for radiolabel analysis. Samples for 
papain treatment were incubated for 16 h at 65~  in 0.05 M sodium acetate, 
pH 5.5,  2  M  NaCI, 0.01 M  cysteine HC1,  and 0.01 M  EDTA containing 
2  mg/ml  recrystallized  papain.  Chromatography  was  on  a  column  of 
Sepharose CL-4B as above. 
Bulk Preparations of  Proteoglycans and 
Antiserum Production 
To each 5-10 liter batch of medium, 3-5 ml of radiolabeled medium was 
added as a tracer for subsequent proteoglycan purification. The first stage 
was by anion-exchange  chromatography essentially as before (8) except that 
a  3  x  5-cm column of DEAE-Sephacel was loaded at 50-100 ml/h. 
After salt gradient elution, fractions from the first peak (Fig. 1) in 0.05 M 
sodium acetate, pH 4.0, 4 M urea, and protease inhibitors (8) were pooled 
and solid cesium chloride was added directly to a  starting density of 1.4 
g/ml. Centrifugation was at 100,000 g for 72 h at 4~  2-ml fractions were 
eluted from the bottom of the tubes, and an aliquot from each was analyzed 
for radiolabel content and density. Those fractions eluting at the bottom 
(density  1.45 g/ml) were pooled and dialyzed into PBS for ion exchange 
chromatography by HPLC. 5-ml aliquots were applied to a Mono Q column 
at 2 ml/min and eluted with a linear gradient of 0.2-1.6 M NaCI in 0.05 M 
sodium acetate, pH 4.0, at 2 rnl/min. 1-Ird fractions were collected and ana- 
lyzed for radiolabel content, pooled (see below), and dialyzed into PBS for 
antiserum production.  Samples were treated with chondroitinase ABC or 
nitrous acid and chromatographer on a column of Sephadex G-50 to confirm 
absence of CS/DSPGs. 
As an approximate guide to protein content, it was estimated that protein 
was present to the equivalent of 10% of the glycosaminoglycan concentra- 
tion and the HSPG in PBS was analyzed spectrophotometrically at 220 or 
230 nm using heparan sulfate chains (a gift from Dr. M. HOOk) as a stan- 
dard.  1 nag HSPG by protein content in PBS was mixed with an equal vol- 
ume of Freund's complete adjuvant and injected subcutaneously in a New 
Zealand white rabbit which was pre-bled before injection to provide preim- 
mune serum. The pre-bleed was used to check a lack of preexisting reactiv- 
ity to rat tissue antigens. 2 and 4 wk later, the rabbit was boosted with HSPG 
at a  similar concentration in Freund's incomplete adjuvant. Bleeds were 
taken from an ear vein at two-wk intervals. The data presented below are 
based on the eighth and ninth bleeds. 
Bulk preparations of PYS-2 culture supernatants were also used to purify 
the CS/DSPG. The preparation was as above for HSPG, except that the sec- 
ond peak of material eluting from the DEAE-Sephacel was used (see be- 
low). This has previously been shown to be rich in CS/DSPG (8). To remove 
contaminating HSPG the material was dialyzed into 0.1 M sodium acetate, 
pH 7.0, containing 1 mM calcium acetate, 0.2 mM PMSE and 1 mM ben- 
zamidine HC1.  Before enzyme addition, 50 p.g/ml leupeptin was added to 
the proteoglycan mixture. 0.25 U/nil each of heparitinase and heparinase 
were added for a 4-5-h incubation at 42~  The CS/DSPG was then recov- 
ered  in  the void  volume of a  30  x  2-cm column of Sephadex  G-200 
equilibrated and run at 10 ml/h in 0.2 M sodium chloride, 20 mM Tris-HCI, 
pH 7.5,  with protease inhibitors as before.  Under this regime, the HSPG 
core protein and heparan sulfate degradation products were included in the 
column.  Hexosamine analysis confirmed  the  absence  of HSPG  in  the 
CS/DSPG preparation (also confirmed by lack of activity of the anti-HSPG 
serum against this material; see below). 
One bulk preparation of medium proteoglycans from PF-HR9 cells was 
used in the analyses of the anti-HSPG serum and was prepared by a single 
ion-exchange chromatography procedure on a 3  ￿  5-cm column of DEAE- 
Sephacel as described above. 
ELISA 
96-well plates were sensitized with 100 ng antigen/well in carbonate buffer, 
pH 9.8, for 2 h at 37~  washed with PBST (PBS containing 0.15%  Tween 
20), and incubated with antisera in PBST for  1 h at 37~  After repeated 
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bit IgG coupled to horseradish peroxidase (CooperBiomedical, Inc., Mal- 
vern, PA) in PBST for 1 h at 37~  The plates were then washed five times 
with PBST, twice with distilled water, and color developed with DMAB/ 
MB'TH chromophore reagent, at 100 gl/well. The color was developed for 
20 min at room temperature and absorbance read on a multiskan (Dynatech 
Laboratories, Inc., Alexandria, VA) at 540 nm. Control wells, not shown 
on the figures, include use of inappropriate peroxidase-conjugated second 
antibody,  lack of antigen,  first antibody or second antibody,  and use of 
preimmune sera from the same rabbits that were subsequently used for rais- 
ing antisera. All of these controls rendered absorbance readings at back- 
ground levels. 
Immunoblotting Analysis of the Antiserum 
Electropboresis was performed as previously (8) on 3-15% gradient SDS 
gels. Electrophoretic transfer onto cationized nylon membranes (Zetaprube; 
Bio-Rad Laboratories,  Richmond, CA) for 2  h at 0.2 A, and then 4  h at 
0.6 A, was in 0.192 M glycine, 0.024 M "Iris. In some cases, molecular mass 
standards or total protein were visualized on the membrane using a biotinyl- 
ation technique, followed by avidin-peroxidase. Briefly,  the method was as 
follows. The membrane was washed in PBS, then in 0.05 M sodium borate, 
0.5 M  NaCI, 5.0%  1-methyl 2-pyroUidinone, 0.2% Tween-20, pH 9.3,  for 
10 min. 100 ml fresh borate buffer containing 200 Ixl of 75 mM N-hydroxy- 
succinimide biotin (Boehringer Mannheim Biochemicals, Indianapolis, IN) 
in dimethylformamide was added for 15 min with constant agitation. The 
membranes were  washed once  in  100  ml  borate  buffer;  then in 0.5  M 
NaCI, 0.02  M  Tris-HCl, pH 7.5,  0.2%  Tween-20, 5%  l-methyl 2-pyrol- 
lidinone before adding  100  gl horseradish peroxidase-conjugated avidin 
(Boehringer Mannheim Biochemicals) in 100 ml Tris-tween buffer for 1 h. 
Washes in Tris-tween buffer and Tris-saline were followed by color develop- 
ment with 4chloro-l-naphthol (Bio-Rad Laboratories) as per manufacturer's 
instructions. 
For immunoblotting the membranes were blocked,  following electro- 
phoretic transfer with TBS/milk (0.5 M  NaC1, 0.05 M  Tris-HCl, pH 7.5, 
containing 0.5% dried milk powder) for at least 6 h. Primary antibody incu- 
bations were performed overnight at a 1:100 dilution in TBS/milk. A 1:3,000 
dilution of horseradish peruxidase-conjugated goat anti-rabbit IgG (Bio- 
Rad Laboratories) in TBS/milk was incubated for 1 h with the membranes 
as secondary antibody, followed by several washes and color development 
as per manufacturer's instructions. 
Approximately 0.5 nag wet weight per lane of frozen EHS tumor (a gift 
from Dr. D. Abrahamson, University of Alabama at Birmingham) was dis- 
solved directly in SDS sample buffer containing dithioerythreitol. All sam- 
ples for electrophoresis, when reduced, were alkylated with 0.5 M  iodo- 
acetamide. Lyophilized large EHS tumor HSPG (a gift from Dr. S. Ledbetter, 
the Upjohn Company, Kalamazoo, MI) was hydrated in 2  M  guanidinium 
hydrochloride in neutral buffer, and then dialyzed into heparitinase/hepa- 
rinase buffer. Some samples were treated with 0.25 U/ml of both bepari- 
tinase and heparinase for 4 h at 42~  as above except that 0.5 mg/ml ovalbu- 
rain  was added  to  further  reduce  proteolytic  attack on the HSPG  core 
protein. 
Preparation of Total PYS-2 Culture 
Supernatant Proteins 
Confluent PYS-2 cultures in eight 150-cm  2 flasks were washed with serum- 
free DME and then incubated with 30 ml/flask serum-free DME for 6 h at 
37~  The medium was harvested, spun at 1,000 rpm to remove cellular de- 
bris, and solid polyethylene glycol (Mr ~  8,000 D) added to  10%  wt/vol. 
After stirring overnight at 4~  the precipitated proteins were sedimented 
by centrifugation at 16,000 rpm for 30 min at 4~  in a Sorvall RC-5B cen- 
trifuge with SA600 rotor.  The precipitates were thoroughly washed with 
90% ethanol and solubilized directly with reducing buffer for SDS-PAGE. 
Samples were immunoblotted, viewed directly by silver staining of a fixed 
gel, or resolved by biotinylation followed by avidin peroxidase after transfer 
to cationized nylon membranes. 
Dotblotting Technique 
Proteoglycans were applied to hydrated cationized nylon membranes in a 
dotblotting apparatus (Bio-Rad Laboratories) at 1190 I.tl/well and left to drain 
through the membrane for 2 h. Vacuum was then applied to draw the re- 
mainder of the liquid  through the membrane. The membrane was then 
blocked with TBS/milk for at least 4 h at room temperature. Washes were 
with TTBS (TBS containing 0.2 % purified Tween 20; Pierce Chemical Co., 
Rockford, IL).  Primary antibodies (200 gl total volume per well) diluted 
in TTBS/milk were incubated for at least 2 h or occasionally overnight. Af- 
ter  serial  washing with  TTBS,  horseradish peroxidase-conjugated goat 
anti-rabbit IgG (Bio-Rad Laboratories) at  1:3000 dilution in TTBS/milk 
(200 I.tl total  volume per well) was incubated with the membrane for  1 h 
at room temperature. Color development was as above for immunoblotting. 
Where anti-HSPG serum was preincubated with PYS-2 or EHS tumor 
HSPGs, the antiserum was diluted in TTBS/milk as above and allowed to 
incubate with 5 p.g/ml  HSPG isolated from PYS-2 culture supernatants or 
5 ~tg/ml large, low density HSPG from the EHS tumor. Preincubation was 
for 1 h at 25~  before adding the antibody/antigen mixture to the wells for 
an additional 3 h  at 37~ 
Immunohistochemical  Staining 
Fresh adult rat tissues were snap-frozen in isopentane chilled in a solid car- 
bon dioxide/acetone bath and processed further as previously described 
(37).  The primary rabbit antisera were anti-mouse laminin, anti-human 
type IV collagen, and anti-PYS-2 HSPG, used at 1:50,  1:40, and 1:30 dilu- 
tions in PBS, respectively. The antiserum against human type IV collagen 
has been characterized previously (37).  That against EHS tumor-derived 
laminin was a gift from Dr. G. J. Harrap (Unilever Research, Colworth Lab- 
oratory, Bedford, U.K.) was monospecific, having no activity against mu- 
rine type IV procollagen, fibronectin, entactin, or basement membrane pro- 
teoglycans. The anti-HSPG serum is characterized below. 
After incubation with primary antibodies, the sections were washed with 
PBS, and then incubated with a  1:40 or 1:50 dilution of a FITC-conjugated 
F(ab)2 fragment of goat anti-rabbit IgG [F(ab)2 fragment specific (Cooper- 
Biomedical, Inc.)] for 45 min. at 37~  in a wet box. Finally the sections 
were washed in PBS and mounted for viewing on the microscope. 
As with all the immunological techniques described here, controls in- 
cluded the use of preimmune sera from the rabbits which were subsequently 
used to raise antisera. A further control in the immunofluorescence studies 
was the use of fluorochrome-conjugated antibody alone, without primary 
antiserum incubation. In all cases, the controls gave low levels of fluores- 
cence by comparison with positively stained sections. 
Neuromuscular Junction Studies 
Fresh rat thigh muscle was teased into single fibers under a dissecting micro- 
scope in PBS and stained unfixed with 100 p.g/ml TRITC-conjugated r 
garotoxin (Molecular Probes,  Inc.,  Eugene, OR) to detect acetylcholine 
receptors, and anti-HSPG or anti-laminin sera under the same conditions 
as above. In double-stained preparations the ct-bungarotoxin and primary 
antiserum were added simultaneously. After a 45-min incubation at room 
temperature and thorough washing in PBS, the preparations were treated 
with fluorescein-conjugated goat anti-rabbit IgG as before. 
Microscopy 
All sections were viewed on a Nikon Optiphot fitted with phase-contrast and 
epiillumination optics and appropriate filters to prevent fluorescence break- 
through. This was checked on single-stained specimens from the neuromus- 
cular junction studies. Micrographs were taken on Ilford HP5 film. Where 
negative controls were photographed, the same exposure time as the appro- 
priate positively stained specimen was used in each case. In double fluores- 
cence experiments, the fluorescein image was photographed first. 
Results 
Characterization of the PYS-2 HSPG 
35  [  S]Sulfate-labeled proteoglycans released into the medium 
from PYS-2 cultures were harvested by anion-exchange chro- 
matography, the column being eluted with an increasing salt 
gradient.  The elution profile (Fig.  1)  revealed two partly 
resolved peaks of radioactivity, and by subjecting each of the 
two pools to degradation by nitrous acid and chondroitinase 
ABC, it was found that the first peak contained on average 
90% heparan sulfate. The second peak contained an average 
of '~70%  chondroitin/dermatan sulfate.  These results are 
similar to those reported previously (20).  The material elut- 
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Figure 1.  Anion exchange chromatogra- 
phy  of [35S]sulfate-labeled PYS-2  cul- 
ture supernatants.  A linear salt gradient 
of 0.2-1.5  M NaCI at pH 4.0 was used 
to elute the column. Fractions  enriched 
in HSPG were  pooled (bar)  and taken 
for further analysis.  Bulk culture super- 
natants  were  taken  through  their  first 
purification  stage by similar chromatog- 
raphy. 
,0.[ 
75O 
om 
500 
o 
o  < 
E 
250 
￿9  HSPG 
cl  HSPG/papain 
o  HSP~  OH-/BH 4 
Vo  v t 
!  ! 
30  35  40  45  50  SS  60  65  70  75  80  86  gO 
ELUTED  VOLUME  (ml) 
Figure 2. Gel chromatography 
on  a  column  of  Sepharose 
CL-4B of [35S]sulfate-labeled 
HSPG from PYS-2 culture su- 
pernatants.  Intact  proteogly- 
cans and  papain  or alkaline/ 
borohydride-treated  proteogly- 
cans were chromatographed  in 
the  presence  of  0.1% SDS, 
0.35  M  NaCI,  0.05 M  Tris- 
HCI,  pH  8.0, and  protease 
inhibitors. 
ing in the first pool was taken for further analysis after re- 
moval of contaminating chondroitin/dermatan sulfate by treat- 
ment with chondroitinase ABC followed by repurification on 
DEAE-Sephacel (not shown).  The purified heparan sulfate 
eluted with a  Kav of 0.30 on a  column of Sepharose CL-4B 
in the presence or absence of SDS indicating an Mr of 200- 
300 kD. Further samples of proteoglycan were reduced and 
alkylated  in the presence of SDS and chromatographed on 
a  column of Sepharose CL-4B in the presence of SDS (not 
shown).  There was no change in elution profile,  indicating 
that this HSPG is not present as a disulfide-bonded dimer or 
oligomer. Furthermore, since the elution profile of the HSPG 
chromatographed in the presence of PBS or SDS were virtu- 
ally identical,  it would appear that there is little tendency of 
this  proteoglycan  to  aggregate  under  physiological  condi- 
tions. 
The proteoglycan nature of this  heparan  sulfate material 
was confirmed by papain digestion followed by gel filtration 
chromatography. This caused a shift of the peak on a column 
of Sepharose CL-4B to Kay 0.38-0.43  and alkaline elimina- 
tion produced an even larger shift to K~v 0.61 (Fig. 2). These 
data suggest that papain digestion leaves large protein rem- 
nants  attached  to each glycosaminoglycan chain,  or,  more 
likely,  that papain releases peptides  containing several gly- 
cosaminoglycan chains,  these  separated  by small  protease- 
resistant  segments of protein core. 
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Figure 3. HSPG-containing fractions from bulk cultures to which 
a trace amount of [3SS]sulfate-labeled  medium had been added and 
chromatographed as in Fig.  1 were subjected to cesium chloride 
density gradient centrifugation. Starting density was 1.4 g/ml. Note 
that virtually all the radiolabeled HSPG was measured from frac- 
tions having a density >1.4 g/ml. 
The elution profile of isolated heparan sulfate chains re- 
leased  by  alkaline  elimination  on  a  column of Sephadex 
G-200 gave a single peak with Kay 0.30 indicating an Mr of 
17-18 kD (36). Further treatment of isolated chains showed 
them to be susceptible to nitrous acid degradation (not shown). 
Amino acid and hexosamine analysis of the proteoglycan 
(Neame, P., and J. R. Couchman, unpublished data) verified 
that a large amount of glucosamine was present, consistent 
with an HSPG. These properties indicate that the proteogly- 
can described here is closely similar to that previously de- 
scribed from PYS-2 cells (24, 33). 
Preparation of the Rabbit Antiserum against 
the PYS-2 HSPG 
After addition of trace quantities of [35S]sulfate-radiolabeled 
medium to 5-10 liter batches, the HSPG was purified in a 
three-stage procedure,  starting with  anion-exchange chro- 
matography and elution with a salt gradient as shown previ- 
ously in Fig. 1. Material eluting in the first peak was pooled, 
brought to a starting density of 1.4 g/ml with solid cesium 
chloride and  subjected  to  density  gradient  centrifugation 
(Fig. 3). A very large proportion of the [35S]sulfate-labeled 
HSPG eluted in the bottom fractions of density ~1.5 g/ml 
(Fig. 3). Very little radiolabel was detected in the region of 
1.3 g/ml density where a previously reported large HSPG 
from both PYS-2 cells and the EHS tumor has been isolated 
(10, 14,  33). 
Final purification was by ion-exchange HPLC on a Mono 
Q  column.  Salt gradient elution revealed polydispersity in 
terms of charge characteristics and a conservative pooling 
excluded material of higher sulfation, as indicated in Fig. 4. 
Pooled proteoglycan fractions were then dialyzed into PBS 
for immunization. HSPG represented >95 % of the total sul- 
fated macromolecules as judged by chromatography of the 
treated radiolabeled material on a column of Sephadex G-50 
after chondroitinase ABC digestion (not shown). 
Characterization of the Anti-HSPG Serum 
The antiserum was tested by a variety of techniques to show 
specificity for HSPG. By ELISA, no reactivity of the serum 
against  murine  laminin,  human  type IV  collagen,  or  rat 
fibronectin could be detected (Fig.  5).  Polyclonal antisera 
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Figure 4. Final purification of PYS-2 bulk culture su- 
pernatants  by  HPLC  anion-exchange chromatogra- 
phy. Up to 5-ml samples in PBS were loaded on to a 
Mono Q colunm and eluted with a 0.2-1.6 M NaC1 
gradient at pH 4.0. Eluted material was analyzed for 
tracer [35S]sulfate-labeled  HSPG. Fractions shown by 
the bar were pooled, concentrated, and injected into 
a rabbit.  Further  samples were subjected to amino 
acid and hexosamine analysis. 
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ANTISERUM  DILUTION 
Figure 5.  ELISAs with the anti-HSPG serum against 100 rig/well 
murine laminin (a), human type IV collagen (b),  and rat plasma 
fibronectin (c). In each case, a fully characterized antiserum against 
the appropriate antigen was also used (solid symbols). Open squares 
denote the reaction of the anti-HSPG serum, and show no detect- 
able reactivity with any antigen. Preimmune serum from the same 
rabbit that was used to raise the anti-HSPG was also used in this 
assay, and gave similar results to the immune serum (not shown). 
against each substrate molecule gave a  strong  response in 
each case. A lack of reactivity of the antiserum against the 
CS/DSPG synthesized by PYS-2 cells (8) was confirmed by 
dotblotting (Fig. 6) and immunoblotting (not shown). In im- 
munoblotting, the antiserum gave a positive response to the 
HSPG (Fig. 7 A). One important feature of the immunoblot- 
ting was the failure of the HSPG to migrate substantially fur- 
ther into the SDS-PAGE gel after a combination of hepari- 
tinase  and  heparinase  treatment;  this  feature  is  discussed 
below. 
A further immunoblotting experiment on a preparation of 
chondroitinase ABC-digested proteoglycans from the close- 
ly related murine cell line, PF-HR9 (Fig. 7 B) showed that 
the anti-HSPG had no reactivity towards CS/DSPGs. In ad- 
dition,  there was evidence for a hybrid HS/CSPG released 
Figure 6.  Dotblot analysis on 
cationized  nylon  membrane 
of the  reactivity  of the  anti- 
HSPG  serum  to  PYS-2-de- 
rived  HSPG  and  CS/DSPG. 
Rows  B-D  were  sensitized 
with  1 lag, 0.5 p,g, and 0.1  lag 
HSPG, respectively;  rows E- 
G  were  sensitized  with  the 
same quantities of CS/DSPG, 
respectively.  Rows A  and  H 
were treated with  1% ovalbu- 
min.  Lanes 1 and 2 received 
preimmune  serum  from  the 
rabbit  that  was used  to raise 
the antibodies (lanes 3 and 4), 
either at a 1:100 dilution (lanes 
1  and  3)  or  1:200 dilution 
(lanes 2  and 4).  The antise- 
rum while  reacting  with  the 
HSPG does not appear to rec- 
ognize the native CS/DSPG. 
to the medium of this cell line. A polyclonal antiserum (R44) 
raised against chondroitinase ABC-treated bovine nasal car- 
tilage proteoglycan, which has activity against the carbohy- 
drate stubs generated by the enzyme (8) and hence is reactive 
with all CS/DSPGs after chondroitinase ABC treatment, re- 
vealed a very disperse band at high molecular mass consis- 
tent with a hybrid proteoglycan. In addition, a closely spaced 
doublet of CS/DSPG core proteins of'~30 kD was also pres- 
ent (lane 4, arrow) which probably corresponds to that seen 
in PYS-2 cultures described previously (8). Importantly, nei- 
ther of these species was detectable with the anti-HSPG se- 
rum (lane 2). In contrast, a high molecular mass diffuse band 
of material was detected by the anti-HSPG serum (lane 2), 
which is not CS/DSPG based on its lack of reactivity with 
R44 (lane 4). These results confirm that the anti-HSPG has 
no  activity  against  chondroitin  sulfate-  or  dermatan  sul- 
fate-containing proteoglycans. 
Immunoblotting of EHS tumor extracts separated by SDS- 
PAGE confirmed that the antiserum had no reactivity towards 
murine laminin,  type IV collagen,  or other tumor compo- 
nents  (Fig.  8),  and  further  showed  the  specificity of the 
anti-laminin and anti-type IV collagen sera (see also refer- 
ence 20) used in this study. Although shown below that the 
anti-PYS-2  HSPG  serum does  cross  react with  the  large 
EHS tumor HSPG, this could not be demonstrated by immu- 
noblotting against total EHS tumor proteins, presumably as 
a result of insufficient proteoglycan content in the tumor ma- 
trix (see reference  10). 
To check for reactivity of the antiserum with other proteins 
released by PYS-2 cells into the culture medium, polyethyl- 
ene glycol precipitation of serum-free culture supernatants 
was analyzed by immunoblotting with anti-HSPG and an- 
tisera against laminin and type IV collagen. As shown in Fig. 
9,  a  large number of polypeptides was detectable by silver 
staining of the gel and by a biotinylation/avidin peroxidase 
technique after electrophoretic transfer of these polypeptides 
to cationized nylon membrane. The anti-HSPG serum only 
reacted with a broad band of high molecular mass material, 
consistent with proteoglycan. It has been shown above (Fig. 
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rum  with  intact  or  heparitinase/heparinase 
digested  PYS-2  HSPG.  2.8  v,g HSPG before 
(lane 2) or after (lane 3) enzyme digestion was 
run on a 3-15 % gradient SDS-PAGE and elec- 
trophoretically transferred  to cationized  nylon 
membrane and probed with the anti-HSPG se- 
rum.  Although  gel  chromatography  showed 
digestion  products  and  hexosamine  analysis 
confirmed  the  presence  of glucosamine  (see 
text), the only change in electrophoretic pattern 
was a broadening  of the band.  Lane I  shows 
molecular  mass  markers  revealed  by  bio- 
tin/avidin  peroxidase  on the membrane.  Mo- 
lecular masses (in kilodaltons)  are assigned  to 
the  markers.  (B)  Lack  of reactivity  of the 
anti-HSPG  serum  with  chondroitin  sulfate- 
and  dermatan  sulfate-containing  proteogly- 
cans.  Chondroitinase  ABC-treated total  pro- 
teoglycans  from the  murine  endodermal  cell 
line PF-HR9 were separated on a 3-15% SDS- 
PAGE minigel and transferred  to cationized ny- 
lon membrane.  Lane 1 shows prestained  mo- 
lecular mass markers (shown  in kilodaltons). 
Lane 2 shows a single broad band staining with 
anti-HSPG serum at the top of the gel. Lane 3 
is stained with preimmune serum and lane 4 is 
stained  with R44, a polyclonal  antiserum  recognizing chondroitin/dermatan sulfate stubs remaining  on core proteins  after chondroitinase 
ABC treatment.  A broad band of large size  is detected  along with a closely spaced doublet of peptides  of "~30 kD (arrow). Neither of 
these CS/DSPGs is stained  in lane/.  Moreover,  the diffuse nature of the large proteoglycan  in lane 4 is potentially  indicative of a hybrid 
molecule to which other glycosaminoglycan chains (e.g., heparan sulfate)  are still attached. 
Figure 8. Immunoblot of EHS tumor probed with antibodies against 
laminin  (lane 3),  type IV collagen  (lane  5), and HSPG (lane  7). 
The preimmune sera appropriate  to each of the three sera are shown 
in lanes  4,  6, and  8,  respectively.  Lane 1 shows  molecular mass 
markers  (arrows): myosin  (200  kD);  13-galactosidase (116 kD); 
phosphorylase B (94 kD); BSA (68 kD); ovalbumin  (45 kD); car- 
bonic anhydrase  (31  kD-not well  resolved);  and  soybean  trypsin 
inhibitor  (21.5 kD). These and a lane  showing  total  protein  (lane 
2)  were  stained  by  biotin/avidin  peroxidase.  The  proportion  of 
HSPG in the tumor was presumably very low and  not resolvable 
6) that there is no cross-reaction with a  DSPG synthesized 
by PYS-2 and PF-HR9 cells (8). These results also confirm 
a  lack  of reactivity  with  laminin  and  type IV collagen of 
PYS-2 origin or any other polypeptides from PYS-2 culture 
supernatants. 
Relationship of the PYS-2 HSPG to EHS Tumor HSPG 
Two distinct HSPGs have been isolated from the EHS tumor 
(10, 14): one, with a large protein core and low, buoyant den- 
sity when analyzed by cesium chloride density gradient cen- 
trifugation; the other, a small, high density HSPG, immuno- 
logically  related  to  the  larger  form  (10, 14)  and  possibly 
derived  from it by proteolytic processing (14). 
Fig.  10 shows a clear reaction by immunoblotting of both 
the native and heparitinase/heparinase  digested core protein 
of the large HSPG with the antiserum  raised against PYS-2 
HSPG.  Several polypeptides are,  in fact, recognized by the 
antiserum  after  enzymatic  digestion  which  may  represent 
subspecies or degradation products of a single high molecu- 
lar mass core protein. The strong response of the anti-HSPG 
serum to EHS tumor core protein indicated (a) the similarity 
of core protein epitopes and (b) that a major part of the poly- 
clonal  response  is  directed  towards  the  proteoglycan core 
protein. The antiserum also recognized the intact and hepari- 
tinase/heparinase-treated  EHS  tumor proteoglycan by dot- 
(cf.  Fig.  10), but  the  figure  shows  a  lack  of reactivity  of the 
anti-HSPG serum with  other major components such as iaminin 
and  type IV collagen. 
Couchman Basement  Membrane Heparan Sulfate Proteoglycans  1907 Figure 9.  Reactivity  of the anti-HSPG 
serum  with  macromolecules  isolated 
form the culture  supernatants  of PYS-2 
cells  by polyethylene  glycol precipita- 
tion.  (Lanes 1-3) Silver  stained  3-15% 
SDS-polyacrylamide  minigel  showing 
molecular mass markers (lane 1 ), myo- 
sin (200 kD); phosphorylase B (97 kD); 
BSA (68 kD); ovalbumin (43 kD); ct-chy- 
motrypsinogen (26 kD); 13-1actoglobulin 
(18.5 kD); and cytochrome C (12.3 kD). 
Total  precipitated  proteins  are  shown 
lanes 2 and 3. Lanes 4-14 were electro- 
phoretically  transferred  to  cationized 
nylon  membrane.  Transfer  was  con- 
firmed by biotin/avidin peroxidase (lanes 
5  and  6).  Twice  as much protein  was 
loaded in lanes 3 and 6 as in lanes 2 and 
5.  Lane  4  shows  the  transfer  of pre- 
stained  molecular mass markers.  (Lanes 7 and 14) Probed with the appropriate  preimmune serum for the anti-HSPG; (lanes 8 and 13) 
anti-HSPG; (lanes  9 and 12) anti-laminin; (lanes 10 and 11) anti-type IV collagen.  The anti-laminin lanes have been overdeveloped  so 
that the small amount of type IV collagen synthesized  by these PYS-2 cells  is visible at 180-190 kD. Arrowheads to the right of lane 14 
show the position of prestained  molecular mass markers as they transferred  to the membrane.  (Arrow) The boundary of the stacking gel 
to resolving  gel. 
blotting (Fig.  11), indicating that cross-reactivity can occur 
with both SDS-denatured and native HSPG. 
These results follow earlier findings that both high and low 
density PYS-2 HSPGs are recognized by antibodies  raised 
against low density HSPGs from EHS tumor (33) and con- 
firm their antigenic  similarity. 
Although under the culture conditions used here, no large, 
low density proteoglycan could be detected in  [3~S]sulfate- 
labeled  material  either by gel filtration chromatography or 
cesium chloride density gradient centrifugation,  a  dotblot- 
ting experiment was performed to confirm that the antiserum 
was  monospecific  and  did  not  separately  recognize  two 
populations of HSPG. The antiserum was preincubated with 
Figure I0. The anti-HSPG se- 
rum  cross  reacts  with  the 
large, low density HSPG from 
the EHS tumor.  5  Ixg HSPG 
was  loaded  in each  of lanes 
2-5, either before (lanes 2 and 
4)  or  after  (lanes  3  and  5) 
heparitinase  digestion.  Elec- 
trophoretically  separated prod- 
ucts  on  a  3-15%  SDS  poly- 
acrylamide  gel  were  trans- 
ferred  to  cationized  nylon 
membrane  and  probed  with 
anti-HSPG  serum  (lanes  2 
and 3) or the appropriate  pre- 
immune  serum  (lanes  4  and 
5).  Several  "core  proteins" 
recognized by the  antiserum 
appear to have been liberated 
by heparitinase treatment. The 
smaller  subspecies  were pos- 
sibly proteolytically derived  from a larger form. Molecular mass 
markers are denoted by arrowheads and correspond to those in Fig. 7. 
(Arrow) The boundary of the stacking  gel to resolving  gel. 
the small  PYS-2 HSPG or large EHS tumor HSPG before 
exposure  to the  same or alternate  substrate-adsorbed  pro- 
teoglycans  (Fig.  11). Preincubation  of the  antiserum  with 
excess PYS-2 high density HSPG virtually eliminated all re- 
activity to the EHS tumor HSPG and PYS-2 HSPG. Preincu- 
bation of the antiserum with low density EHS tumor HSPG, 
on the other hand, removed all reactivity to that antigen, but 
some activity against the PYS-2 HSPG remained.  Taken to- 
gether, these results indicated that the antiserum was indeed 
monospecific,  and confirmed an antigenic  relationship  be- 
tween these HSPGs from PYS-2 and EHS tumor sources as 
reported previously (10, 33). In addition, these experiments 
indicated that the PYS-2 HSPG contained epitopes not repre- 
sented on the EHS tumor HSPG. 
HSPG Distribution in Adult Rat Tissues 
A  preliminary survey of a number of rat tissues by indirect 
immunofluorescence  on  frozen  sections  was  carried  out. 
Sections were stained with the anti-HSPG serum, anti-lami- 
nin, or anti-type IV collagen sera. The results are shown in 
Figs.  12-15 and are summarized in Table I. While a wide va- 
riety of basement membranes all stained positively for lami- 
nin and type IV collagen, only specific subsets stained with 
antiserum against the PYS-2 HSPG. Epithelial (Figs.  12-14), 
mesothelial  (Fig.  12,  g-i),  and  endothelial  (Figs.  12-14) 
basement membranes  from a  number of rat tissues  stained 
with all three antisera.  The exception was liver,  where the 
sinusoidal  basement membranes  were positive for type IV 
collagen (Fig.  14 b) and negative for HSPG (Fig.  14 a). Kid- 
ney tubular and glomerular basement membranes were par- 
ticularly well stained with the anti-HSPG serum (Fig.  14, c 
and d).  Basement membranes which were negative for the 
HSPG included those associated with some electrically ex- 
citable  tissues,  but  in  each  case  the  same  structures  were 
clearly  positive  for  laminin  and  type  IV  collagen.  Most 
smooth muscle tested including that of esophagus, small in- 
testine,  uterus,  bladder,  and tracheole (Figs.  12 d,  13 a,  13 
The Journal of Cell Biology, Volume 105. 1987  1908 Figure 11. Absorption of the anti-HSPG serum with PYS-2 HSPG 
or EHS tumor large HSPG.  EHS HSPG (rows A-C) or PYS-2 
HSPG (rows D-F) were dotted on to cationized nylon membrane 
at 0.5 ltg/well (rows A and D), 0.1 I~g/well  (rows B and E), or 0.02 
Ixg/well (rows C and F). Lane 5 has no HSPG, but contained 1 
mg/well ovalbumin. After blocking the membrane with ovalbumin, 
the wells had an equal amount of anti-HSPG serum or preimmune 
serum added. Lane 1 received the antiserum with no further addi- 
tions and shows reactivity with both proteoglycans. The antisera for 
each well in lanes 2 and 3 were preadsorbed for I h with 1 lag PYS-2 
HSPG (lane 2) or EHS HSPG (lane 3). While virtually all reactiv- 
ity has been blocked in lane 2, absorption with EHS HSPG only 
partially abrogates reactivity towards a PYS-2 HSPG substrate, but 
completely blocks reactivity with an EHS HSPG substrate. Lane 
4  received  preimmune  serum  while  lane  5  received  immune 
anti-HSPG serum. 
d) were unlabeled for HSPG as was cardiac muscle (Fig.  14 
g), and the neuromuscular junction of striated muscle (see 
below). Aortic and peripheral vascular smooth muscle (Figs. 
13 a,  14 a and 14 e) and striated muscle (Fig.  16) were, how- 
ever, positively labeled for HSPG and strongly stained for 
laminin and type IV collagen. 
Attempts to uncover potentially masked HSPG epitopes by 
pretreatment of tissue sections with heparitinase/heparinase, 
chondroitinase ABC, or leech'hyaluronidase before antibody 
treatment did not alter the staining pattern of any of the three 
antisera (not shown). Since the polyclonal anti-HSPG used 
in these studies stained a large number of basement mem- 
branes, and two other basement membrane components were 
consistently demonstrable, it seemed likely that the HSPG 
recognized by the antiserum to PYS-2 high density HSPG 
was absent or present to a minimal extent in a particular sub- 
set of muscle basement membranes. 
In a further examination of the distribution of this type of 
HSPG with tissues where membrane depolarization is  in- 
volved in functional activity, sections of  pancreas and parotid 
gland  were  stained  with  antisera  to  basement  membrane 
components (Fig.  15). It has been suggested that pancreatic 
acinar cells in particular undergo membrane depolarization 
as a result of neuronal and hormonal stimulation, resulting 
in the release of digestive enzymes from the luminal surface 
(27).  Consistent  with  this,  the basement membranes  sur- 
rounding the pancreatic acini, but not those of the parotid 
gland (Fig. 15) were devoid of staining for this form of HSPG. 
The basement membranes of  blood vessel endothelia, partic- 
ularly  those  of pancreatic  islet  capillaries,  were  strongly 
stained with the anti-HSPG serum on the same tissue sec- 
tions (Fig. 15 a). Not only were parotid gland acini positive, 
but all the ductular basement membranes in this organ con- 
tained this proteoglycan (Fig. 15 c). In contrast, laminin and 
type IV  collagen  were  readily displayed in  all  basement 
membranes of these glands. 
Liver epithelium is known to be a rich source of cell sur- 
face  associated  HSPG  which  has  hydrophobic properties 
(20). The anti-HSPG serum failed to stain liver epithelium 
in frozen sections (Fig. 14 a) indicating that membrane-inter- 
calated  HSPG  is  probably  antigenically  unrelated  to  the 
basement membrane form discussed here.  However, liver 
blood  vessel  basement  membranes  were  strongly  stained 
with the anti-HSPG serum in the same sections. 
Absence of  PYS-2 HSPG at the 
Neuromuscular Junction 
Several previous reports have highlighted the presence of 
HSPG in Xenopus and chick embryo neuromuscular junc- 
tion (1, 2, 4) and in vitro there is reported to be a consider- 
able concentration of proteoglycan in this structure after ex- 
perimental  manipulation  (I).  To  further  characterize  the 
PYS-2 HSPG, fresh adult rat striated muscle was teased into 
single  fibers  and  stained,  either with  anti-HSPG  serum, 
anti-laminin serum,  or rhodamine-labeled r 
to detect acetylcholine receptors, either singly or in double 
staining.  Although the neuromuscular junction and motor 
end plates could be easily stained with a-bungarotoxin (Fig. 
16 a), no co-distribution with the antiserum against PYS-2 
HSPG could be detected. General endomysial staining for 
HSPG could be seen in the same preparations (Fig. 16, b and 
c) even though this was consistently weak. Over 100 motor 
end plates were examined in double-stained preparations, all 
of which lacked any detectable staining with anti-HSPG se- 
rum, whereas co-distribution of laminin with acetylcholine 
receptors was detected (Fig.  16, g-i), indicating that steric 
hindrance did not hinder antibody penetration into the neu- 
romuscular junction. It would appear, therefore, that concen- 
trations of  HSPG at adult rat neuromuscular  junction, should 
they occur in a similar way to other systems (1, 2, 4), do not 
involve the HSPG characterized here. 
Discussion 
In this report, a small, high buoyant density HSPG released 
into culture supernatants of PYS-2 cells has been character- 
ized and purified, and a monospecific antiserum has been 
raised against it. This proteoglycan, by virtue of its hydro- 
dynamic properties and  glycosaminoglycan chain  size,  is 
closely similar to that described previously from this cell 
Couchman Basement  Membrane  Heparan  Sulfate Proteoglycans  1909 Figure 12. Immunohistochemical staining of frozen sections of adult rat skin (a-c), esophagus (d-f), and lung (g-i) with anti-HSPG serum 
(a, d, and g), anti-laminin serum (b, e, and h), anti-type IV collagen serum (c and f), or preimmune serum from the rabbit used to raise 
the anti-HSPG serum (i).  Arrows in a-f indicate the basement membranes underlying the stratified epithelia; arrowheads denote upper 
dermal capillaries (a-c) or venules (d-f). Curved arrows in a-c mark follicular epithelial basement membrane. While esophageal smooth 
muscle was stained  for laminin and type IV collagen (curved arrows, e and f), this was not stained with the anti-HSPG serum (curved 
The Journal of Cell Biology. Volume 105. 1987  1910 Figure 13. Frozen sections  of rat bladder (a-c) and ileum (d-f) stained with antisera  against PYS-2 HSPG (a and d), laminin (b and e), 
and type IV collagen (c and  f), In all cases, epithelial (arrows) and blood vessel endothelial  basement membranes (arrowheads) are stained. 
In contrast to laminin  and type IV collagen, the inner longitudinal  and outer circular bladder smooth muscles were not positive  for the 
HSPG (SM; a-c). Similarly,  the muscularis mucosa (MM) and inner circular and outer longitudinal  smooth muscles of the ileum (SM) 
were unstained  with anti-HSPG serum. A positively  stained arteriole  in the serosa of the bladder is marked in a (curved arrow). Bars: 
(a-c)  100 I~m; (d-f) 50 I.tm. 
type (24, 33). Results from immunoblotting assays and ELISAs 
confirmed  that  the  antiserum  had  no  reactivity  with  the 
DSPG synthesized by these cells (8), laminin, type IV colla- 
gen, fibronectin, or other polypeptides of PYS-2 or EHS tu- 
mor origin.  In addition,  no evidence was found to suggest 
that the antiserum has any reactivity with the glycosamino- 
glycan portion of PYS-2 HSPG and reactivity of the antise- 
rum with heparitinase/heparinase-treated  proteoglycan was 
demonstrated  by  immunoblotting  and  in  vivo  staining.  It 
therefore  appears  likely that the antiserum  recognizes epi- 
topes on the core protein of the proteoglycan although it re- 
mains possible that the antiserum also has reactivity to N- or 
O-linked oligosaccharides. 
The limited susceptibility of PYS-2 HSPG to heparitinase/ 
heparinase (Fig. 7 a), in contrast to that from the EHS tumor, 
is of some interest.  To rule out the possibility of a  hybrid 
HS/CSPG being responsible for this result, supernatant pro- 
teoglycans from the murine  endodermal  cell  line  PF-HR9 
were subjected to chondroitinase ABC and immunoblotting. 
All CSPGs or DSPGs were detected with an antiserum (R44) 
recognizing the carbohydrate stubs remaining on CS/DSPGs 
after enzyme treatment.  There was no common recognition 
arrows, d). Basement  membranes of lung mesothelium were stained  for HSPG and laminin  (arrows) as were those of alveolar epithelia 
and capillary endothelia (g and h).  No staining  was seen with preimmune serum (i).  Bars,  50 ~m. 
Couchman Basement  Membrane  Heparan  Sulfate Proteoglycans  1911 Figure 14. Frozen sections of rat liver (a and b), kidney (c and d), aorta (e and f), and heart ventricle (g and h) stained with anti-HSPG 
serum (a, c, e, and g), anti-type IV collagen serum (b), and anti-laminin serum (d, f, and h). While hepatic blood vessels were positive 
for HSPG, sinusoidal basement membranes were apparently unstained (but were stained with anti-type IV collagen serum; b). Kidney 
tubular and glomerular (arrows) basement membranes (c and d) were strongly stained with anti-HSPG and anti-laminin. The intima and 
media of aorta were also stained (e and f), as were vasa vasorum in the adventitia (arrowheads). Cardiac muscle (g and h) apart from 
blood vessels (arrowheads; g) was unstained with anti-HSPG serum, but the muscle basement membranes were strongly positive with 
anti-laminin serum (h). Bars, 50 ~tm. 
The Journal of Cell Biology, Volume 105, 1987  1912 Figure 15. Sections of rat pancreas (a and b) and parotid gland (c 
and d) stained with anti-HSPG serum (a and c) and anti-laminin 
serum (b and d). While pancreatic islet capillaries (arrows) and 
other blood vessels (curved arrows) were stained for both basement 
membrane components,  acinar  basement  membranes apparently 
lacked the  HSPG (see arrowhead for example). In comparison, 
both acinar (arrows) and intralobular duct (arrowheads) basement 
membranes of the parotid gland were positive for both components. 
Bars: (a and b)  100 ltm; (c and d) 50 gm. 
of any proteoglycan species by R44 and the anti-HSPG se- 
rum further indicating that the latter was specific for HSPG. 
In addition, the experiment provided evidence for a hybrid 
proteoglycan in PF-HR9 supernatants. Such molecules have 
been  described  from other cell  types before (9,  28),  but 
whether the mouse endodermal variety is of cell surface ori- 
gin or is secreted directly to the medium along with other 
basement membrane components is currently unknown. 
The antigen, although somewhat resistant to heparitinase/ 
heparinase treatment, was identified as an HSPG by hexos- 
amine analysis (Neame, P., and J. R. Couchman, unpublished 
data) and sensitivity to nitrous acid deamination. A previous 
report (25) has shown that an HSPG from kidney glomerular 
basement membrane exhibited partial resistance to nitrous 
acid which was thought to result from reduced N-sulfation of 
glucosamine residents close to the core protein. Thus, a par- 
ticular disposition of sulfate groups and/or iduronate resi- 
dues may explain the relative resistance of the PYS-2 HSPG 
to bacterial enzyme degradation (see reference 12). Further- 
more, it was also proposed that the heparan sulfate chains in 
a bovine glomerular HSPG were clustered in a small portion 
of the core protein (25) consistent with the fact that the PYS- 
2 HSPG was not totally papain sensitive, the enzyme releas- 
ing peptides bearing several glycosaminoglycan chains. 
There are now many reports of HSPGs isolated from the 
medium or extracellular matrix of cultured cells, and from 
intact basement membranes of tissue origin.  Two HSPGs 
have been  isolated from the matrix of the EHS tumor:  a 
large, low buoyant density HSPG and a smaller, high buoyant 
density HSPG (10, 14, 38). These have been shown to be im- 
munologically related in that antisera raised against one form 
cross-react with the other (10, 14), which in turn has given 
rise  to  speculation  that  the  larger  form gives  rise  to  the 
smaller by way of limited proteolysis (14). As shown here, 
the antiserum raised against the small, high density HSPG 
from PYS-2 cultures cross reacted with the large, low density 
HSPG from the EHS tumor. This raised the possibility that 
the polyclonal antiserum had activities against two different 
HSPGs or that there was antigenic similarity of the two pro- 
teoglycans.  Absorption  of the  antiserum  with  the  PYS-2 
HSPG or with the large HSPG from the EHS tumor com- 
pletely abrogated reaction with the large EHS HSPG, verify- 
ing the monospecificity of the antiserum and therefore, the 
close similarity of the two proteoglycans despite differences 
in  core  protein  size.  On  the  other  hand,  the  absorption 
studies showed that the antiserum still reacted with the PYS-2 
HSPG after preabsorption with the EHS tumor HSPG, thus 
implying that there are epitopes on the PYS-2 HSPG not 
present on the EHS tumor HSPG, even though the latter has 
a much larger core protein. This may result from different 
oligosaccharides, from conformational differences between 
the two core proteins, or from the fact that the EHS tumor 
HSPG may have some differences in protein sequence from 
that of the PYS-2 proteoglycan. The intriguing relationship 
between core proteins of HSPGs can only be resolved with 
protein sequence data, but studies on CSPGs (16) have shown 
that an antigenic relationship does not necessarily correlate 
with a closely related overall core protein structure. 
The immunohistochemical study presented here demon- 
strated the unusual distribution of the HSPG antigen. By far 
the majority of basement membranes were positively stained 
with the anti-HSPG, anti-laminin, and anti-type IV colla- 
gen sera including those underlying most epithelia, mesothe- 
lia,  and  endothelia.  However,  the  basement  membranes 
of most  smooth  and  cardiac  muscle  were  negative  when 
stained with the anti-HSPG serum although brightly labeled 
for the other two basement membrane components. In con- 
trast, blood vessel and capillary endothelial basement mem- 
branes including those associated with muscle which were 
not positive for the HSPG were distinctly stained for all three 
components in the same tissue sections. Aortic and periph- 
eral blood vessel smooth muscle basement membranes were 
stained with antisera against all three basement membrane 
components showing that not all smooth muscle was negative 
for this type of HSPG. Although staining of endomysial base- 
ment membranes in cross sections of striated muscle was not 
strong, it was clearly visible in enface staining of freshly dis- 
sected skeletal muscle fibers. Since a polyclonal antiserum 
was used in these experiments and treatment of tissue sec- 
tions with heparitinase/heparinase, chondroitinase ABC, or 
hyaluronidase had no effect on staining for HSPG, it seems 
Couchman Basement  Membrane  Heparan  Sulfate Proteoglycans  1913 Figure 16.  Absence of the PYS-2 form of HSPG at the neuromuscular junction of rat striated muscle. Freshly teased postaxial hindleg 
muscle was stained for neuromuscular  junction by TRITC-a-bungarotoxin  (a, d, and g). In double-stained preparations, end plates (a and 
b) and neuromuscular  junction zones (d-i) could not be stained with anti-HSPG serum (b and e). Neuromuscular junction could, on the 
other hand, be stained with anti-laminin  serum (h). fand i show matching phase-contrast micrographs. Curved arrows mark matched simms. 
Open arrows in b,  e, and h  show general endomysial staining for HSPG (b and c) and laminin (h). Bars, 50 ~tm. 
The Journal of Cell Biology, Volume 105, 1987  1914 Table L  Basement Membrane Staining with Antiserum 
against a PYS-2-derived HSPG 
Cell type  Tissue  Staining 
Epithelia  Skin  + 
Esophagus  + 
Kidney tubule  + 
Kidney glomerulus  + 
Bronchiole  + 
Bladder  + 
Uterus  + 
Ileum  + 
Liver 
Pancreas acini 
Parotid acini  + 
Parotid ducts (intra- and interlobular)  + 
Mesothelia  Lung  + 
Endothelia  Major and minor blood vessels 
(arterial and venous)  + 
Capillaries  + 
Muscle  Striated  (+) 
Striated-neuromuscular junction 
Smooth: Aortic  + 
Peripheral blood vessels  (+) 
Esophagus 
Bronchiole 
Bladder 
Uterus 
Ileum 
Cardiac 
(+) denotes staining which was often weak. 
highly probable that many smooth muscle types and cardiac 
muscle lack this form of HSPG in their basement membranes. 
Alternatively, the HSPG in these basement membranes may 
be in very much lower concentrations or be complexed in 
such a way to cause antigenic masking or steric hindrance 
of  antibody penetration. Previous reports showing variability 
in tissue laminin and type IV collagen staining have con- 
cerned monoclonal antibodies where antigenic masking was 
a distinct possibility (11, 35). 
One implication of these results is that for at least some 
smooth muscle and cardiac muscle, an alternative form of 
HSPG may be present. This form presumably has a core pro- 
tein of sufficiently different characteristics that there is no 
antigenic relationship with the HSPG under study in this re- 
port. Additionally, it is also quite feasible that many base- 
ment membranes contain more than one HSPG. The fact that 
a group of muscle tissues are unstained implies that there is 
a correlation between their function and the nature of base- 
ment membrane composition. 
The basement membranes of smooth and cardiac muscle 
abut the plasma membrane where the proteoglycans may ex- 
ert their  influence.  Bearing  in  mind  the  requirement for 
membrane  depolarization to  be  accompanied by  calcium 
influx in these muscle types and the capacity of proteogly- 
cans to bind with cations or perhaps control their diffusion 
(3, 23), it is tempting to speculate that electrostatic shielding 
or some function involving the availability of extracellular 
calcium for influx resulting from stimulation to contract in- 
volves certain proteoglycan species. On the other hand, stri- 
ated muscle, with its abundant "T" tubule and sarcoplasmic 
reticulum network as calcium sources, may not use the same 
extracellular ion control mechanisms. In addition, vascular 
smooth muscle (which as striated muscle stained with the 
anti-HSPG serum) may also use calcium release from sub- 
membraneous sarcoplasmic reticulum in its contractile ac- 
tivity (34). 
The  idea  of extracellular  cation  availability  being  as- 
sociated with or controlled by basement membrane is sup- 
ported by the finding that those of pancreatic acini were also 
not stained with the anti-HSPG serum. In this case, it has 
been proposed that membrane depolarization may be part of 
or a consequence of secretagogue stimulation (27, 39) and 
that basolateral extracellular calcium is important for en- 
zyme and fluid release from the luminal surface of acinar 
cells under prolonged stimulus and for maintenance of  a high 
resting membrane potential and resistance (27).  Unlike the 
pancreas, however, the parotid gland acinar basement mem- 
branes contained the HSPG investigated here, perhaps indic- 
ative of different control mechanisms with regard to secre- 
tion (39). 
Although there are now reports that one or more forms of 
basement membrane HSPG are located at the neuromuscu- 
lar junction and may have a role to play in the orientation or 
localization of acetylcholinesterase (1,  2,  4),  fluorescence 
studies showed that while motor end plates could be readily 
detected  by  rhodamine-conjugated  a-bungarotoxin,  there 
was no commensurate staining with the anti-HSPG serum. 
In the same experiment, double fluorescence studies resulted 
in endomysial staining of the muscle fibers with anti-HSPG 
serum, and antibodies against laminin stained the neuromus- 
cular junction showing that antibody penetration into this 
zone was not sterically hindered. An antigenically distinct 
form of HSPG may thus be associated with these specialized 
zones. However, using a monoclonal antibody, others have 
shown that quite widely distributed HSPG species have some 
antigenic  similarity  to  that  located  at  the  neuromuscular 
junction (4, 29). It is clear that further detailed characteriza- 
tion will be required to elucidate basement membrane pro- 
teoglycan relationships. 
Major and minor blood vessel endothelia stained intensely 
with the anti-HSPG serum, but in contrast no staining of the 
thin, patchy basement membranes of rat liver sinusoids was 
detected. Type IV collagen was, however, detectable in this 
basement membrane. It remains possible, just as with the ap- 
parently  negative  muscle  and  acinar  epithelial  basement 
membranes, that the HSPG was present at levels below that 
which could be detected by indirect immunofluorescence mi- 
croscopy. 
One major class of HSPGs is the hydrophobic type at the 
cell surface of many cells including liver epithelia and fibro- 
blasts (6, 9,  17, 20,  28, 40). In vitro studies indicate a role 
for hydrophobic HSPGs in cell adhesion to the extracellular 
matrix through an association with the microfilament-based 
cytoskeleton (17, 40, 41). An antiserum against cell surface 
HSPG from liver epithelial cells has been shown previously 
to cross react with fibroblast cell surfaces (41). The antise- 
rum against PYS-2 HSPG did not stain liver epithelia or 
PYS-2 cell surfaces (Couchman, J. R., unpublished results), 
and studies in progress further indicate that fibroblast cell 
surfaces are also not stained (Woods, A., J. R. Couchman, 
and  M.  H6/Sk, manuscript  in  preparation).  This together 
Couchman Basement  Membrane  Heparan Sulfate Proteoglycans  1915 with previous evidence (31, 32)  strongly suggests that the 
core proteins of cell surface and basement membranes HSPGs 
are distinct and immunologically unrelated.  Furthermore, 
the fact that the antiserum only stained basement membranes 
indicates that it has no activity against cell surface forms of 
HSPG. 
Finally, bearing in mind the present and previous data con- 
cerning the presence of CS/DSPGs in basement membranes 
(5, 7,  18), it is probable that a family of proteoglycans are 
present in these specialized extracellular matrices, each of 
which may have specific roles to play in the physiology of 
epithelial or parenchymal growth and differentiation. 
Grateful  thanks are extended  to Dr.  P.  Neame for amino acid  and  hexos- 
amine analysis, and to Dr. G. J. Harrap (Unilever Research, Col~rth Lab- 
oratory,  Bedford,  U.K.) for help with raising of the antiserum and gifts of 
antisera to  laminin  and  type IV collagen.  Technical  assistance from Ms. 
H.  Minter,  Ms.  L.  Lewis,  and Ms.  C.  Foulger (Unilever Research),  and 
R.  Austria, M. D., Ms. S. J. Bright,  and Ms. N. Spears (University  of Ala- 
bama at  Birmingham) is also gratefully  acknowledged.  I also thank  Dr. 
S.  R.  Ledbetter  (The  Upjohn Company, Kalamazoo,  MI) for the gift  of 
heparan sulfate  proteoglycan  from EHS tumor, and  Dr.  D.  Abrahamson 
(Birmingham) for the samples of EHS tumor. 
These studies  were started  while J. R. Couchman was a senior scientist 
at  Unilever  Research,  Colworth Laboratory,  Sharnbrook, Bedford,  UK. 
This investigation  was supported by grants from the National  Institutes 
of Health  (AR36457),  the  Atherosclerosis Research  Unit,  Diabetes  Re- 
search and Training  Center,  and Diabetes  Trust Fund at University  of Ala- 
bama at Birmingham. 
Received  for publication  4  March  1987, and in revised  form 4 June  1987. 
References 
I. Anderson,  M. J.  1986. Nerve-induced remodeling of muscle basal lamina 
during  synaptogenesis. J.  Cell Biol.  102:863-867. 
2. Anderson,  M. J.,  F.  G.  Klier,  and K.  E.  Tanguay.  1984. Acetylcholine 
receptor  aggregation  parallels  the  distribution  of a  basal lamina pro- 
teoglycan during  development  of the  neuromuscular junction.  J.  Cell 
Biol.  99:1769-1784. 
3.  Arnott, S., and A. K. Mitra.  1984. X-ray diffraction analyses ofglycosami- 
noglycans. In Molecular Biophysics of the Extracellular Matrix.  S. Ar- 
noU, D. A. Rees, and E. R. Morris, editors. Humana Press, New Jersey. 
41-67. 
4.  Bayne, E. K., M. J. Anderson, and D. M. Fambrough.  1984. Extracellular 
matrix organization in developing muscle: correlation with acetylcholine 
receptor aggregates. J.  Cell Biol.  99:1486-1501. 
5. Cohn, R. H., S. D. Banerjee, and M. R. Bernfield. 1977. The basal lamina 
of embryonic salivary epithelia: nature of glycosaminoglycan and organi- 
zation of extracellular  materials. J.  Cell Biol.  73:464-478. 
6. C~ister, L.. I. Carlstedt,  S. Kendall, A. Malmstr6m,  A. Schmidtcher, and 
L.-A.  Fransson.  1986. Structure  of proteoheparan  sulfates from fibro- 
blasts. J.  Biol.  Chem.  261:12079-12088. 
7. Couchman,  J.  R., B.  Caterson,  J.  E.  Chrismer,  and J.  R.  Baker. 1984. 
Mapping  by  monoclonal antibody  detection  of glycosaminoglycans  in 
connective tissues. Nature  (Lond.).  307:650-652. 
8. Couchman, J. R., A. Woods, M. H66k, andJ. E. Christner.  1985. Charac- 
terization of a dermatan sulfate proteoglycan synthesized by murine pari- 
etal yolk sac (PYS-2) cells. J.  Biol.  Chem.  260:13755-13762. 
9.  David, G., and H. van der Berghe.  1985. Heparan sulfate-chondroitin sul- 
fate hybrid proteoglycan at the cell surface and basement membrane of 
mouse mammary epithelial cells. J.  Biol.  Chem.  260:11067-11074. 
10.  Dziadek, M., S. Fujiwara, M. Paulsson, and R. Timpl.  1985. Immunologi- 
cal characterization of basement membrane types of heparan sulfate pro- 
teoglycan. EMBO  (Eur.  Mol.  Biol.  Organ.) J.  4:905-912. 
11.  Fitch, J. M., R. Mayne, and T. F. Linsenmayer.  1983. Developmental ac- 
quisition of basement membrane heterogeneity:  type IV collagen in the 
avian lens capsule. J.  Cell Biol.  97:940-943. 
12.  Gallagher, J. T., M. Lyon, and W. P. Steward.  1986. Structure and func- 
tion of heparan sulfate proteoglycans.  Biochem.  J.  236:313-325. 
13.  Hassell, J. R., J. H. Kimura, and V. C. Hascall.  1986. Proteoglycan core 
protein  families. Annu.  Rev.  Biochem.  55:539-567. 
14.  Hassell,  J.  R.,  W.  C.  Leyshon,  S.  R.  Ledbetter,  B.  Tyree,  S.  Suzuki, 
M. Kato, K. Kimata, and H. K. Kleinman.  1985. Isolation of two forms 
of basement membrane proteoglycans.  J.  Biol.  Chem.  260:8098-8105. 
15.  Hassell, J. R., D. M. Noonan, S. R. Ledbetter, and G. W. Laurie.  1986. 
Biosynthesis and structure of the basement membrane proteoglycan con- 
taining heparan sulfate side-chains.  Ciba Found.  Symp.  124:204-222. 
16.  Heineg~rd, D., A. FranzEn, E. Hedbom, and Y. Sommarin.  1986. Com- 
mon structures  of the core  proteins  of interstitial  proteoglycans.  Ciba 
Found.  Symp.  124:82-88. 
17.  H66k, M., L. KjellEn, S. Johansson, and J. Robinson.  1984. Cell-surface 
glycosaminoglycans.  Annu.  Rev.  Biochem.  53:847-869. 
18.  Kanwar, Y. S., V. C. Hascall, and M. G. Farquhar.  1981. Partial charac- 
terization of newly synthesized proteoglycans  isolated from glomerular 
basement membrane. J.  Cell Biol.  90:527-532. 
19.  Kanwar, Y. S.,  A. Linker, and M. G. Farquhar.  1980. Increased perme- 
ability of glomerular  basement  membrane to ferritin  after  removal of 
glycosaminoglycans (heparan sulfate) by enzyme digestion. J.  Cell Biol. 
86:688-693. 
20.  Kjell6n, L., I. Pettersson,  and M. H66k.  1981. Cell-surface heparan sul- 
fate:  an  intercalated  membrane  proteoglycan.  Proc.  Natl.  Acad.  Sci. 
USA.  78:5371-5375. 
21.  Laterra, J., J. E. Silbert, and L. A. Culp.  1983. Cell surface heparan sulfate 
mediates  some adhesive  responses  to glycosaminoglycan-binding  ma- 
trices,  including fibronectin. J.  Cell Biol.  96:112-123. 
22.  Lehman, J.  M., W. C.  Speers, D. E. Swartzendruber,  and G. B. Pierce. 
1974. Neoplastic differentiation: characteristics of  cell lines derived from 
a murine teratocarcinoma.  J.  Cell Physiol.  84:13-28. 
23.  Lerner, L. and D. A. Torchia.  1986. A multinuclear NMR study of the in- 
teractions  of cations  with  proteoglycans,  heparin  and  ficoll.  J.  Biol. 
Chem.  261:12706-12714. 
24. Oohira, A., T. N. Wight, J. McPherson, and P. Bornstein. 1982. Biochem- 
ical and ultrastructural  studies of proteoheparan  sulfates synthesized by 
PYS-2,  a  basement  membrane-producing  cell  line. J.  Cell  Biol.  92: 
357-367. 
25.  Parthasarathy,  N., and R. G.  Spiro.  1984. Isolation and characterization 
of the heparan sulfate proteoglycan of the bovine glomerular basement 
membrane. J.  Biol.  Chem.  259:12749-12755. 
26.  Paulsson,  M., S.  Fujiwara,  M.  Dziadek,  R. Timpl,  G.  Pejler,  G.  Back- 
strom,  U. Lindahl, and J.  Engel.  1986. Structure and function of base- 
ment membrane proteoglycans.  Ciba Found.  Symp.  124:189-203. 
27.  Peterson, O. H., and N. lwatsuki.  1978. The role of calcium in pancreatic 
acinar  cell stimulus-secretion  coupling:  an  electrophysiological  ap- 
proach.  Ann.  N.  Y. Acad.  Sci.  307:599-617. 
28.  Rapraeger, A. C., M. Jalkanen, E. Endo, J. Koda, and M. Bernfield. 1985. 
The cell surface proteoglycan from mouse mammary epithelial cells bears 
chondroitin  sulfate  and  heparan  sulfate  glycosaminoglycans.  J.  Biol. 
Chem.  260:11046-11052. 
29.  Sanes, J. R., M. Schachner, and J. Covault.  1986. Expression of several 
adhesive macromolecules (N-CAM, L I, J 1, NILE, uvomorulin, laminin, 
fibronectin and a heparan sulfate proteoglycan) in embryonic,  adult and 
denervated adult skeletal muscle. J.  Cell Biol.  102:420-431. 
30.  Shively, J. E., and H. E.  Conrad.  1976. Formation of anhydrosugars  in 
chemical depolymerization  of heparin.  Biochemistry.  15:3932-3942. 
31.  Stow, J.  L., and M. G. Farquhar.  1986. Distinctive basement membrane 
and  membrane-intercalated  heparan  sulfate proteoglycans  (HSPG)  are 
produced by cultured cells. J.  Cell Biol.  103(5, Pt.  2):262a.  (Abstr.) 
32.  Stow, J. L., H. Sawada, and M. G. Farquhar.  1985. Basement membrane 
heparan sulfate proteoglycans are concentrated in the laminae rarae and 
in podocytes of the rat renal glomerulus.  Proc.  Natl.  Acad.  Sci.  USA. 
82:3296-3300. 
33. Tyree,  B.,  E. A. Horigan,  D. L. Klippenstein,  and J.  R.  Hassell.  1984. 
Heterogeneity  of heparan  sulfate proteoglycans  synthesized by PYS-2 
cells. Arch.  Biochem.  Biophys.  231:328-335. 
34.  van Breeman, C., P. Leyten, H. Yamamoto, P. Aaronson, and C. Cauvin. 
1986.  Calcium  activation  of vascular  smooth  muscle.  Hypertension. 
8(Suppl. 2):89-95. 
35. Wan, Y.-J., T.-C. Wu, A. E. Chung, and I. Damjarov.  1984. Monoclonal 
antibodies to laminin reveal the heterogeneity of basement membranes in 
the developing and adult mouse tissues. J.  Cell Biol.  98:971-979. 
36. Wasteson, A,.  1971. A method for the determination of the molecular weight 
and molecular weight distribution of chondroitin sulfate. J.  Chromatogr. 
5: 89 -97. 
37. Westgate, G. E., D. A. Shaw, G. J. Harrap,  and J. R. Couchman.  1984. 
Immunohistochemical localization of basement  membrane components 
during hair follicle morphogenesis.  J.  Invest.  Dermatol.  82:259-264. 
38. Wewer,  U. M., R. Albrechtsen, and J. R. Hassell.  1985. Heparan sulfate 
proteoglycans made by different membrane-producing  tumors have im- 
munological and structural similarities.  Differentiation.  30:61-67. 
39. Williams,  J.  A.  1984. Regulatory  mechanisms in pancreas  and  salivary 
acini. Annu.  Rev.  Physiol.  46:361-375. 
40.  Woods,  A.. J. R. Couchman,  and M.  Hf6k.  1985. Heparan sulfate pro- 
teoglycans  of rat  embryo  fibroblasts.  A  hydrophobic  form may  link 
cytoskeleton and matrix components. J. Biol. Chem. 260:10872-10879. 
41.  Woods,  A., M.  H66k,  L. Kjell~n, C.  G. Smith,  and D. A. Rees.  1984. 
Relationship of heparan sulfate proteoglycans to the cytoskeleton and ex- 
tracellular  matrix of cultured fibroblasts. J.  Cell Biol.  99:1743-1753. 
The Journal of Cell Biology, Volume  105, 1987  1916 